Wilbanks Smith & Thomas Asset Management LLC Crispr Therapeutics Ag Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$61.1 - $83.78 $38,676 - $53,032	633 Added 14.17%	5,101 $333,000
Q1 2022 May 05, 2022	BUY	$53.19 - $79.24 $87,125 - $129,795	1,638 Added 57.88%	4,468 $235,000
Q4 2021 Feb 08, 2022	SELL	$70.09 - $111.29 $4.68 Million - $7.43 Million	-66,767 Reduced 95.93%	2,830 $214,000
Q3 2021 Nov 04, 2021	BUY	$110.2 - $156.64 $7.4 Million - $10.5 Million	67,125 Added 2715.41%	69,597 $7.79 Million
Q2 2021 Aug 04, 2021	BUY	$100.84 - $161.89 $47,596 - $76,412	472 Added 23.6%	2,472 $400,000
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $159,340 - $346,460	2,000 New	2,000 $306,000

Others Institutions Holding CRSP

# of Institutions

488

Shares Held

59M

Call Options Held

1.09M

Put Options Held

1.9M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

8.97M
Shares

$356 Million
3.09% of portfolio
Capital International Investors Los Angeles, CA

7.93M
Shares

$315 Million
0.07% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$119 Million
0.01% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$118 Million
1.61% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$110 Million
0.0% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account